AU2001261343A1 - Method of regulating angiogenesis using ryk protein - Google Patents
Method of regulating angiogenesis using ryk proteinInfo
- Publication number
- AU2001261343A1 AU2001261343A1 AU2001261343A AU6134301A AU2001261343A1 AU 2001261343 A1 AU2001261343 A1 AU 2001261343A1 AU 2001261343 A AU2001261343 A AU 2001261343A AU 6134301 A AU6134301 A AU 6134301A AU 2001261343 A1 AU2001261343 A1 AU 2001261343A1
- Authority
- AU
- Australia
- Prior art keywords
- regulating angiogenesis
- ryk protein
- ryk
- protein
- angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56878300A | 2000-05-10 | 2000-05-10 | |
US09568783 | 2000-05-10 | ||
PCT/US2001/015043 WO2001085789A2 (en) | 2000-05-10 | 2001-05-09 | Extracellular domain of ryk protein for regulating angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261343A1 true AU2001261343A1 (en) | 2001-11-20 |
Family
ID=24272718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261343A Abandoned AU2001261343A1 (en) | 2000-05-10 | 2001-05-09 | Method of regulating angiogenesis using ryk protein |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1287121A2 (en) |
JP (1) | JP2004527206A (en) |
AR (1) | AR028424A1 (en) |
AU (1) | AU2001261343A1 (en) |
CA (1) | CA2408349A1 (en) |
CO (1) | CO5300464A1 (en) |
DO (1) | DOP2001000164A (en) |
EC (1) | ECSP014068A (en) |
GT (1) | GT200100079A (en) |
PE (1) | PE20011218A1 (en) |
SV (1) | SV2002000442A (en) |
UY (1) | UY26696A1 (en) |
WO (1) | WO2001085789A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1471934A2 (en) * | 2002-02-06 | 2004-11-03 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Kinases involved in the regulation of energy homeostasis |
JO3283B1 (en) | 2011-04-26 | 2018-09-16 | Sanofi Sa | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) |
TR201909951T4 (en) | 2014-07-18 | 2019-07-22 | Sanofi Sa | A method for predicting the outcome of aflibercept treatment of a patient suspected of having cancer. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07506969A (en) * | 1992-05-11 | 1995-08-03 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | Molecules similar to receptor tyrosine kinases |
JPH10512140A (en) * | 1994-12-23 | 1998-11-24 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | Assays, receptor proteins and ligands |
ATE321856T1 (en) * | 1998-06-11 | 2006-04-15 | HUMAN RECEPTOR TYROSINE KINASE | |
WO2000024415A2 (en) * | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
-
2001
- 2001-05-07 AR ARP010102149A patent/AR028424A1/en not_active Application Discontinuation
- 2001-05-07 GT GT200100079A patent/GT200100079A/en unknown
- 2001-05-08 UY UY26696A patent/UY26696A1/en not_active Application Discontinuation
- 2001-05-09 JP JP2001582388A patent/JP2004527206A/en active Pending
- 2001-05-09 AU AU2001261343A patent/AU2001261343A1/en not_active Abandoned
- 2001-05-09 EP EP01935233A patent/EP1287121A2/en not_active Withdrawn
- 2001-05-09 CA CA002408349A patent/CA2408349A1/en not_active Abandoned
- 2001-05-09 SV SV2001000442A patent/SV2002000442A/en not_active Application Discontinuation
- 2001-05-09 EC EC2001004068A patent/ECSP014068A/en unknown
- 2001-05-09 WO PCT/US2001/015043 patent/WO2001085789A2/en not_active Application Discontinuation
- 2001-05-09 CO CO01036462A patent/CO5300464A1/en unknown
- 2001-05-10 PE PE2001000417A patent/PE20011218A1/en not_active Application Discontinuation
- 2001-05-10 DO DO2001000164A patent/DOP2001000164A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001085789A3 (en) | 2002-05-16 |
WO2001085789A2 (en) | 2001-11-15 |
PE20011218A1 (en) | 2002-02-01 |
UY26696A1 (en) | 2001-12-28 |
EP1287121A2 (en) | 2003-03-05 |
ECSP014068A (en) | 2002-02-25 |
GT200100079A (en) | 2001-12-31 |
SV2002000442A (en) | 2002-07-03 |
JP2004527206A (en) | 2004-09-09 |
AR028424A1 (en) | 2003-05-07 |
CO5300464A1 (en) | 2003-07-31 |
CA2408349A1 (en) | 2001-11-15 |
DOP2001000164A (en) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002362197A1 (en) | Method of stabilizing protein | |
AU2001232799A1 (en) | Protein c derivatives | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU2001231085A1 (en) | Method of making protein arrays | |
AU2001236005A1 (en) | Preparations stabilized over long time | |
AU2001241075A1 (en) | Method of anticipating interaction between proteins | |
AU2002232819A1 (en) | Methods for the production of multimeric proteins, and related compositions | |
AU2002306918A1 (en) | Methods of modulating angiogenesis | |
AU2001295450A1 (en) | Method of polypeptide renaturation | |
AU2002223548A1 (en) | Improved method for the biosynthesis of vitamin e | |
AU2001280588A1 (en) | Methods of modulating angiogenesis | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU2002361763A1 (en) | Method of reducing angiogenesis | |
AU2001269077A1 (en) | Methods and means for regulation of gene expression | |
AU2001261343A1 (en) | Method of regulating angiogenesis using ryk protein | |
AU2002354363A1 (en) | Method of activating protein | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2002215956A1 (en) | Regulation of human pgc-1-like protein | |
AU2002231620A1 (en) | Regulation of human patched-like protein | |
AU2001293780A1 (en) | Regulation of human protein phosphatase iic-like enzyme | |
AU5647101A (en) | Over expression of the whn protein | |
AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme |